Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
939,516
-
Share change
-
+192,314
-
Total reported value
-
$66,992,360
-
Price per share
-
$71.30
-
Number of holders
-
77
-
Value change
-
+$13,677,917
-
Number of buys
-
27
-
Number of sells
-
24
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2022
As of 30 Sep 2022,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
939,516 shares.
The largest 10 holders included
MORGAN STANLEY, Peak Asset Management, LLC, Mirae Asset Global Investments Co., Ltd., GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.